Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases

INTRODUCTION: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited. OBJECTIVE: To assess the effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamberts, Aniek, Euverman, H. Ilona, Terra, Jorrit B., Jonkman, Marcel F., Horváth, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827539/
https://www.ncbi.nlm.nih.gov/pubmed/29520266
http://dx.doi.org/10.3389/fimmu.2018.00248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827539/
https://www.ncbi.nlm.nih.gov/pubmed/29520266
http://dx.doi.org/10.3389/fimmu.2018.00248

Ejemplares similares